2024-510671-38-00已完成4 期
A Single Dose, Two – stage, Fasting State, Bioequivalence Study of Rifaximin 200 mg, film-coated tablets (Antibiotice S.A.) vs. Normix® 200 mg, film-coated tablets (Alfasigma S.p.A)
Antibiotice S.A.1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2024年5月23日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Diana Iacob
Scientific
Antibiotice S.A.
研究点 (1)
Loading locations...
相似试验
已完成
不适用
A Study of Viagra and XCalibur in Healthy Volunteers.ACTRN12616001712493iX Biopharma Ltd.48
已完成
1 期
Comparative assessment of the absorption of an Iron Polymaltose tablet against an innovator product conducted in iron deficient participants under fed conditions with diet control (low iron and low fat).Iron DificiencyDiet and Nutrition - Other diet and nutrition disordersBlood - AnaemiaACTRN12623001001684Zenith Technology Corporation Limited24
已完成
1 期
Comparative assessment of the absorption of a generic formulation of Iron Polymaltose tablet against the innovator Maltofer tablet conducted in iron deficient participants under fed conditions with diet control.Iron DificiencyBlood - AnaemiaDiet and Nutrition - Other diet and nutrition disordersACTRN12623000530628Zenith Technology Corporation Limited12
尚未招募
1 期
A single dose study under fasting condition to access the Bioequivalence of Etoricoxib 120 mg tablets (Test formulation), manufactured by Interthai Pharmaceutical Manufacturing Limited with a reference formulation Arcoxia® - MSD, in 24 healthy volunteersBioequivalence study in healthy volunteersBioequivalence,EtoricoxibTCTR20170201002Bio-innova and Synchron.Co.,Ltd24
Unknown
不适用
BE Study of Gaster®D Tab 20mg (Manufacturer Changed)Gastroduodenal UlcerNCT04123899Dong-A ST Co., Ltd.32